Diane Simeone, MD, NYU Langone Health, New York, NY, comments on the application of CAR T-cell therapy for solid tumors and the associated challenges. Dr Simeone highlights the importance of translational studies to help recognize whether the CAR T-cell effectively penetrates the tumor and kills the cancer cells and to identify whether this therapy will be optimal as a monotherapy or in combination with other therapies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.